Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: Effect on survival

Radiology

Volumn 258, Issue 3, 2011, Pages 776-784

  Mironov, Oleg ^a,b   Ishill, Nicole M ^a   Mironov, Svetlana ^a   Vargas, Hebert Alberto ^a   Zheng, Junting ^a   Moskowitz, Chaya S ^a   Sonoda, Yukio ^a   Papas, Ralph S ^a,c   Chi, Dennis S ^a   Hricak, Hedvig ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; ASCITES; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HEALTH STATUS; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; OVARY CARCINOMA; OVERALL SURVIVAL; PLEURA EFFUSION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PLEURAL EFFUSION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 79952308226     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100162     Document Type: Article

References (24)

1. American Cancer Society. Cancer facts & figures 2009. Atlanta, Ga: American Cancer Society, 2009.
2. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers: FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70(2):209-262.
3. Ozols RF. Update on Gynecologic Oncology Group (GOG) trials in ovarian cancer. Cancer Invest 2004;22(suppl 2):11-20. (Pubitemid 40065216)
4. Traill ZC, Davies RJ, Gleeson FV. Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 2001;56(3):193-196.
5. Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990;154(3):487-492. (Pubitemid 20071594)
6. Kim KW, Choi HJ, Kang S, et al. The utility of multi-detector computed tomography in the diagnosis of malignant pleural effusion in the patients with ovarian cancer. Eur J Radiol 2010;75(2):230-235.
7. Bonnefoi H, A'Hern RP, Fisher C, et al. Natural history of stage IV epithelial ovarian cancer. J Clin Oncol 1999;17(3):767-775. (Pubitemid 29109304)
8. Penson RT, Skates SJ, Fuller AJ Jr, Seiden MV. Clinical course of stage IV epithelial ovarian cancer [letter]. J Clin Oncol 1999;17(10):3361-3362. (Pubitemid 29470673)
9. Aletti GD, Podratz KC, Cliby WA, Gostout BS. Stage IV ovarian cancer: disease sitespecific rationale for postoperative treatment. Gynecol Oncol 2009;112(1):22-27.
10. Eitan R, Levine DA, Abu-Rustum N, et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer 2005;103(7):1397-1401. (Pubitemid 40410734)
11. Copeland LJ. Epithelial ovarian carcinoma. In: DiSaia PJ, Creasman WT, eds. Clinical gynecologic oncology. 7th ed. Philadelphia, Pa: Mosby-Elsevier, 2007.
12. Chi DS, Abu-Rustum NR, Sonoda Y, et al. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol 2004;94(2):307-311. (Pubitemid 39024531)
13. Juretzka MM, Abu-Rustum NR, Sonoda Y, et al. The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions. Gynecol Oncol 2007;104(3):670-674. (Pubitemid 46240259)
14. Mergo PJ, Helmberger T, Didovic J, Cernigliaro J, Ros PR, Staab EV. New formula for quantification of pleural effusions from computed tomography. J Thorac Imaging 1999;14(2):122-125. (Pubitemid 29301194)
15. Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary: FIGO 6th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95(suppl 1):S161-S192.
16. Curtin JP, Malik R, Venkatraman ES, Barakat RR, Hoskins WJ. Stage IV ovarian cancer: impact of surgical debulking. Gynecol Oncol 1997;64(1):9-12. (Pubitemid 27026949)
17. Winter WE 3rd, Maxwell GL, Tian C, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2007;25(24):3621-3627. (Pubitemid 47372600)
18. Grunze H. The comparative diagnostic accuracy, efficiency and specificity of cytologic techniques used in the diagnosis of malignant neoplasm in serous effusions of the pleural and pericardial cavities. Acta Cytol 1964;8:150-163.
19. Sallach SM, Sallach JA, Vasquez E, Schultz L, Kvale P. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest 2002;122(6):1913-1917. (Pubitemid 36051124)
20. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10(8):1907-1913. (Pubitemid 27368388)
21. Diaz JP, Abu-Rustum NR, Sonoda Y, et al. Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients. Gynecol Oncol 2010;116(3):483-488.
22. Tokumitsu S, Oka H, Nozaki A, et al. A case of ovarian cancer in which a remarkable effect was seen with intrathoracic administration of CDDP and CPT-11 [in Japanese]. Gan To Kagaku Ryoho 2008;35(12):2237-2238.
23. Mitamura T, Hosaka M, Takeda M, Watari H, Sakuragi N. Intrathoracic injection of paclitaxel for a patient with stage IV serous ovarian cancer: a case report. Cancer Chemother Pharmacol 2009;64(1):169-170.
24. Orki A, Akin O, Tasci AE, et al. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases. Thorac Cardiovasc Surg 2009;57(4):217-221.